Investing with options: Meta Platforms, Inc. earnings Investing with options: Meta Platforms, Inc. earnings Investing with options: Meta Platforms, Inc. earnings

Investing with options: Meta Platforms, Inc. earnings

Options 10 minutes to read
Koen Hoorelbeke

Options Strategist

Summary:  In the wake of Meta's upcoming Q3 earnings release, various options strategies offer intriguing avenues for investors with different market outlooks. From buying long-dated call options for bullish leverage to selling in-the-money puts for effective stock acquisition at a discount, and writing covered calls for additional income, options provide flexibility and strategic depth. Each approach comes with its own risk-reward profile, making options an invaluable tool for navigating earnings season and beyond.


Investing with options - Meta Platforms, Inc. earnings

Meta Platforms, Inc., formerly known as Facebook Inc, is expected to announce its third-quarter earnings on Wednesday, October 25th, after market hours. Analysts have projected an EPS of $3.57 and revenue of $33.43 billion. Despite facing competitive pressure and a slowing advertising revenue growth, Meta is still expected to deliver strong numbers. Regardless of the outcome, options offer versatile strategies for both bullish and bearish investors.
Important note: the strategies and examples provided in this article are purely for educational purposes. They are intended to assist in shaping your thought process and should not be replicated or implemented without careful consideration. Every investor or trader must conduct their own due diligence and take into account their unique financial situation, risk tolerance, and investment objectives before making any decisions. Remember, investing in the stock market carries risk, and it's crucial to make informed decisions.
 

Strategies

1. Bullish outlook - buying call options:

Considering Meta's recent pullback, a long call option can capitalize on potential upside.

  • Execution: BuyToOpen 1 20-Sep-2024 Call 250 @ $94.90 (Delta: 0.81).
  • Premium: Per share: $94.90 (debit)
  • Premium and risk:
    • Premium cost: $94.90 x 100 (per contract) = $9,490
    • Max risk: $9,490 (if Meta remains below 250 at expiry)
    • Max reward: Significant (gains rise as Meta's stock price rises)
  • Breakeven point: $250 (strike) + $94.90 (premium) = $344.90
  • Rationale: Opting for a longer expiration minimizes the impact of time decay (or "theta decay").
  • Stock vs Options Comparison: With the same amount of $9,490, you could buy approximately 30 shares of Meta at its current price of $316.30. If Meta's stock price increases by $1:
    • With the stock, you would make $30 (30 shares x $1).
    • With the call option, your profit would be calculated as follows: 100 (contract multiplier) x $1 (price increase) x 0.81 (Delta) = $81.
 

2. Bullish outlook - selling ITM put options:

 
Selling in-the-money (ITM) put options can be another method to acquire Meta shares at a discount.
  • Execution: SellToOpen 1 27-Oct-2023 Put 327.50 @ $19.55 (Delta: -0.22).
  • Premium: Per share: $19.55 (credit)
  • Premium and risk:
    • Premium earned: $19.55 x 100 (per contract) = $1,955
    • Max risk: Significant (if Meta stock falls significantly)
  • Breakeven point: $327.50 (strike) - $19.55 (premium) = $307.95
  • Rationale: A shorter expiration allows for quicker premium capture, but the risk is owning the stock if it drops below the strike price.
  • Stock vs Options Comparison:
    • The current price of Meta is $316.30. By selling this ITM put option, you get to buy Meta at an effective price of $307.95 per share, thanks to the premium received.
    • Discount in Effective Price: $(316.30 - 307.95) = $8.35 per share
    • Percentage Discount: ($8.35 / $316.30) x 100 = approximately 2.64%
 

3. Bearish outlook - buying put options:

If you believe Meta's stock is set for a decline, a long put option can be suitable.
  • Execution: BuyToOpen 1 20-Sep-2024 Put 380 @ $80.55 (Delta: -0.62).
  • Premium: Per share: $80.55 (debit)
  • Premium and risk:
    • Premium cost: $80.55 x 100 (per contract) = $8,055
    • Max risk: $8,055 (if Meta remains above 380 at expiry)
    • Max reward: Significant (gains rise as Meta's stock price falls)
  • Breakeven point: $380 (strike) - $80.55 (premium) = $299.45
  • Rationale: A longer expiration again helps mitigate the effects of time decay.
  • Stock vs Options Comparison:
    • If Meta’s stock price decreases by $1:
    • With the stock, you would lose $1 per share if you are holding the stock.
    • With the bought put option, your profit would be: 100 x $1 x 0.62 (delta) = $62
 

4. Neutral/bullish outlook - writing covered calls:

If you already own Meta shares, covered calls can generate additional income.
  • Execution: SellToOpen 1 03-Nov-2023 Call 350 @ $3.40 (Delta: 0.19).
  • Premium: Per share: $3.40 (credit)
  • Premium and risk:
    • Premium earned: $3.40 x 100 (per contract) = $340
    • Max risk: Limited to stock ownership
  • Breakeven point: Varies based on stock cost basis
  • Yield for covered call: 11-day yield: 1.07%
    • Annualized yield: 35.56%
  • Rationale: Writing covered calls provides income but caps upside potential. The strategy is effective if you expect the stock to trade sideways or slightly up in the short term.
  • Stock vs Options Comparison:
    • With the stock, you receive no income unless you sell the shares or they pay dividends.
    • With a covered call, you receive immediate income and potentially have the stock called away at $350, which might or might not be beneficial depending on your outlook.
 

Conclusion

When it comes to investing in options around Meta's earnings, each strategy comes with its unique set of rewards and risks. The key is aligning your strategy with your market outlook and risk tolerance.
 
The comparisons between buying stock and using options reveal interesting facets:
 
  • Buying calls: The leverage effect of a call option allows you to control the same amount of stock with less capital. A $1 increase in Meta's stock results in an $81 gain with a call, compared to a $30 gain by holding 30 shares of the stock.
  • Selling ITM puts: This strategy could allow you to acquire Meta at a discounted rate compared to buying shares directly. The effective purchase price would be the strike minus the premium received, which can be calculated as a percentage discount against the current stock price.
  • Buying puts: Options offer a leveraged way to bet against the stock with a defined risk, which can be particularly useful in volatile times.
  • Writing covered calls: This strategy provides additional income and an annualized yield of 35.44%, which you can't get by just holding the stock.
Each option strategy can serve a purpose depending on your viewpoint on the stock and market conditions, making options a flexible tool for various investment goals.

Options are complex, high-risk products and require knowledge, investment experience and, in many applications, high risk acceptance. We recommend that before you invest in options, you inform yourself well about the operation and risks. In Saxo Bank's Terms of Use you will find more information on this in the Important Information Options, Futures, Margin and Deficit Procedure. You can also consult the Essential Information Document of the option you want to invest in on Saxo Bank's website.
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.